DEJORIA JOHN PAUL 13D and 13G filings for Telomir Pharmaceuticals, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 9:24 pm Purchase | 2025-12-31 | 13G | TELOMIR PHARMACEUTICALS INC CO TELO | DEJORIA JOHN PAUL | 3,245,000 9.438% | 1,470,100 (+82.83%) | Filing |
| 2025-09-18 6:48 pm Purchase | 2025-09-09 | 13G | TELOMIR PHARMACEUTICALS INC CO TELO | DEJORIA JOHN PAUL | 1,774,900 5.500% | 1,774,900 (New Position) | Filing |